Prospective observational study of the pancreatic cancer microenvironment in EUS-FNB specimen procured by Franseen needle and chemotherapy response

Prospective observational study of the pancreatic cancer microenvironment in EUS-FNB specimen procured by Franseen needle and chemotherapy response - The pancreatic cancer microenvironment in the EUS-FNB specimen and chemotherapy

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000034264

Enrollment

Registered

2018-09-26

Start date

2018-09-18

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) 20 years<=. 2) Cross-sectional image consistent with pancreatic cancer. 3) Scheduled EUS-FNA. 4) Scheduled chemotherapy. 5) Written informed consent.

Exclusion criteria

Exclusion criteria: 1) Iodine allergy, egg allergy. 2) Coagulopathy. 3) Unsuitable for EUS-FNB. 4) Not obtained written informed consent. 5) Others.

Design outcomes

Primary

Measure	Time frame
To identify the factors in the microenvironment of the pancreatic cancer specimen procured by EUS-FNB influence on the chemotherapy response, PFS, RFS, OS	—

Secondary

Measure	Time frame
- Relation between the tumor vascularity, hardness and the chemotherapy response, PFS, RFS, OS. - To identify the factors in the microenvironment of the tumor specimen influence on neoadjuvant chemotherapy. - To compare the microenvironment between EUS-FNB and the surgically acquired specimen.	—

Countries

Japan

Contacts

Public ContactTesshin Ban

University of Miyazaki Department of Gastroenterology and Hepatology, Faculty of Medicine

venzosan0204@gmail.com0985859797

Outcome results